v3.26.1
Consolidated Balance Sheets - USD ($)
Jun. 30, 2026
Dec. 31, 2025
Assets    
Loans receivable, net of deferred origination and other fees $ 61,772,768 $ 60,218,841
Interest and other fees receivable on loans 1,637,865 1,642,825
Cash 229,547 204,889
Cash – restricted 27,000 23,350
Other assets 125,809 60,742
Right-of-use asset – operating lease, net 74,819 101,226
Deferred financing costs, net 125,716 98,858
Total assets 63,993,524 62,350,731
Liabilities:    
Lines of credit 19,309,466 17,601,132
Accounts payable and accrued expenses 190,002 173,247
Operating lease liability 83,689 112,076
Loan holdback 164,598 50,000
Dividends payable 1,256,806 1,314,732
Total liabilities 21,004,561 19,251,187
Commitments and contingencies
Stockholders’ equity:    
Preferred shares - $.01 par value; 5,000,000 shares authorized; none issued and outstanding
Common shares - $.001 par value; 25,000,000 shares authorized; 11,757,058 issued; 11,425,509 and 11,432,451 outstanding, respectively 11,757 11,757
Additional paid-in capital 45,581,538 45,575,006
Less: Treasury shares, at cost – 331,549 and 324,607 shares, respectively (1,129,013) (1,098,964)
Accumulated deficit (1,475,319) (1,388,255)
Total stockholders’ equity 42,988,963 43,099,544
Total liabilities and stockholders’ equity $ 63,993,524 $ 62,350,731